Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
尼沃单抗和伊匹单抗治疗复发或难治性原发性不明癌症：一项 II 期临床试验
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-023-42400-5
Maria Pouyiourou #, Bianca N Kraft #, Timothy Wohlfromm, Michael Stahl, Boris Kubuschok, Harald Löffler, Ulrich T Hacker, Gerdt Hübner, Lena Weiss, Michael Bitzer, Thomas Ernst, Philipp Schütt, Thomas Hielscher, Stefan Delorme, Martina Kirchner, Daniel Kazdal, Markus Ball, Klaus Kluck, Albrecht Sten
